<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report June 24, 1996
----------------------------
(Date of earliest event reported)
NeXstar Pharmaceuticals, Inc.
-----------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-23012 84-1173453
- --------------------------------------------------------------------------------
(State or other (Commission File (IRS Employer
jurisdiction of Number) Identification No.)
incorporation)
2860 Wilderness Place Boulder, CO 80301
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's Telephone Number, including area code: (303) 444-5893
---------------------------
NA
- --------------------------------------------------------------------------------
<PAGE> 2
ITEM 5. OTHER EVENTS
The Registrant on June 24, 1996 announced that it was withdrawing its
plan to issue an additional 2.5 million shares of common stock in a public
offering as a result of the decline in its stock price.
<PAGE> 3
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
None
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NeXstar Pharmaceuticals, Inc.
By: /s/ Patrick J. Mahaffy
---------------------------
Patrick J. Mahaffy
President
Dated: July 8, 1996
